Again from The Conversation. I see Amgen's T-VEC treatment for melanoma based on an engineered herpes virus costs an eye-watering $65,000 per patient. I'd pay it if I had to but many would struggle to pay that kind of amount. Hopefully VLA will provide better results in combination with PD-1 drugs.
https://theconversation.com/biologics-the-pricey-drugs-transforming-medicine-80258
Add to My Watchlist
What is My Watchlist?